Oral fluids as an alternative to serum for measurement of markers on immune activation

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 4, 1998, Pages 507-512

  Nishanian, Runag ^a,b   Aziz, Najib ^a   Chung, Joanie ^a   Detels, Roger ^a,c   Fahey, John L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE SYSTEM; LIQUID; MOUTH CAVITY; PRIORITY JOURNAL; SALIVA; SALIVARY GLAND; SECRETION;

EID: 2642709210     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.4.507-512.1998     Document Type: Article

References (34)

1. Akalin, F. A., S. Bulut, and E. Yavuzyilmaz. 1993. Beta2-microglobulin levels in serum and saliva of patients with juvenile periodontitis. J. Nihon Univ. Sch. Dent. 35:230-234.
2. Aufricht, C., W. Tenner, H. R. Salzer, A. E. Khoss, E. Wurst, and K. Herkner. 1992. Salivary IgA concentration is influenced by the saliva collection method. Eur. J. Clin. Chem. Clin. Biochem. 30:81-83.
3. Aukrust, P., N. B. Liabakk, F. Müller, E. Lien, T. Espevik, and B. S. Froland. 1994. Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologie parameters. J. Infect. Dis. 169:420-424.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Diez-Ruiz, A., G. P. Tilz, R. Zangerle, G. Baier-Bitterlich, H. Wachter, and D. Fuchs. 1995. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 54:1-8.
6. Dodds, M., S. C. Hsieh, and D. A. Johnson. 1991. The effect of increased mastication by daily gum-chewing on salivary gland output and dental plaque acidogenicity. J. Dent. Res. 70:1474-1478.
7. Evans, M. R. W., and M. H. Wansbrough-Jones. 1995. Saliva and serum neopterin concentrations not significantly correlated in HIV-1 infection. Clin. Chem. 41:950-951.
8. Fahey, J. L., J. M. G. Taylor, R. Detels, B. Hofmann, R. Melmed, P. Nishanian, and J. V. Giorgi. 1990. The prognostic value of cellular and serologic markers in infection with HIV-1. N. Engl. J. Med. 322:166-172.
9. Ferguson, D. B. (ed.). 1984. Steroid hormones in saliva. S. Karger, München, Germany.
10. Fuchs, D., A. Hausen, G. Reibnegger, E. R. Werner, M. P. Dierich, and H. Wachter, 1988. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol. Today 9:150-155.
11. Giorgi, J. V., H.-L. Cheng, J. B. Margolick, K. D. Bauer, J. Ferbas, M. Waxdal, I. Schmid, L. E. Hultin, A. L. Jackson, L. Park, J. M. G. Taylor, and The Multicenter AIDS Cohort Study Group. 1990. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the Multicenter AIDS Cohort Study experience. Clin. Immunol. Immunopathol. 55:173-186.
12. Giovannoni, G., M. Lai, D. Kidd, J. W. Thorpe, D. H. Miller, A. J. Thompson, G. Keir, M. Feldmann, and E. J, Thompson. 1997. Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. Brain 120:1-13.
13. Haeckel, R. 1989. Report on the workshop conference "The Application of Saliva in Laboratory Medicine." J. Clin. Chem. Clin. Biochem. 27:221-252.
14. Haeckel, R. 1990. Saliva, an alternative specimen in clinical chemistry. J. Int. Fed. Clin. Chem. 2:208-216.
15. Hoekman, K., J. A. Van-Nieuwkoop, and R. Willemze. 1985. The significance of beta2-microglobulin in clinical medicine. Neth. J. Med. 28:551-557.
16. Hofmann, B., Y. Wang, W. G. Cumberland, R. Detels, M. Bozorgmehri, and J. L. Fahey. 1990. Serum β2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS 4:207-214.
17. Huber, C., J. R. Batchelor, D. Fuchs, A. Hausen, A. Lang, and D. Nierderwieser. 1984. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160:310-316.
18. Kaslow, R. A., D. G. Ostrow, R. Detels, J. P. Phair, B. F. Polk, and C. R. Rinaldo, Jr. 1987. The multicenter AIDS cohort study: rationale, organization, and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318.
19. Katoh, S., T. Sueoka, S. Matsuura, and T. Sugimoto. 1989. Biopterin and neopterin in human saliva. Life Sci. 45:2561-2568.
20. Lacey, J. N., M. A. Forbes, M. A. Waugh, E. H. Cooper, and M. H. Hambling. 1987. Serum beta2-microglobulin and human immunodeficiency virus infection. AIDS 1:123-127.
21. Maddali Bongi, S., G. Campana, A. D'Agata, C. Palermo, and G. Bianucci. 1995. The diagnosis value of β2-microglobulin and immunoglobulins in primary Sjögren's syndrome. Clin. Rheumatol. 14:151-156.
22. Mortimer, P. P., and J. V. Parry. 1994. Detection of antibody to HIV in liva: a brief review. Clin. Diagn. Virol. 2:231-243.
23. Mucklow, J. C. 1982. The use of saliva in therapeutic drug monitoring. Ther. Drug Monit. 4:229-247.
24. Müller, F., M. Holberg-Petersen, H. Rollag, P. Brandtzaeg, and S. S. Froland. 1992. Nonspecific oral immunity in individuals with HIV infection. J. Acquired Immune Defic. Syndr. 5:46-51.
25. Nishanian, P., J. M. G. Taylor, E. Korns, R. Detels, A. Saah, and J. L. Fahey. 1987. Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELISAs and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population. J. Clin. Microbiol. 25:395-400.
26. Propst, A., T. Propst, M. Herold, W. Vogel, and G. Judmaier. 1995. Inter-leukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol. 7:1031-1036.
27. Read, G. F. 1984. Immunoassays of steroids in saliva, p. 193-201. In G. F. Read, D. Riad-Fahmy, R. F. Walker, and K. Griffiths (ed.), Proceedings of the Ninth Tenevus Workshop. Alpha Omega Publishing Ltd., Cardiff, Wales.
28. Reibnegger, G., D. Fuchs, R. Zangerle, and H. Wachter. 1990. Increased neoptcrin concentration in saliva of patients with HIV-1 infection. Clin. Chem. 36:1379-1380.
29. Rolinski, B., U. Wintergerst, A. Matuschke, H. Füessl, F. D. Goebel, A. A. Roscher, and B. H. Belohradsky. 1990. Evaluation of saliva as a specimen for monitoring zidovudine therapy in HIV-infected patients. AIDS 5:885-888.
30. Rostoker, G., M. A. Pech, M. Petit-Phar, A. BenMaadi, S. Cholin, P. Lang, J. M. Dubert, B. Weil, and G. Lagrue. 1990. Mucosal immunity in adult primary glomerulonephritis. Nephron 54:42-46.
31. SAS Institute. 1985. SAS user's guide: statistics version 5 edition. SAS Institute, Cary, N.C.
32. Schramm, W., D. A. Kidwell, R. H. Smith, and P. A. Craig. 1992. Drugs of abuse in saliva: a review. J. Anal. Toxicol. 16:1-9.
33. Tamashiro, H., and N. T. Constantine. 1994. Serological diagnosis of HIV infection using oral fluid samples. Bull. W.H.O. 72:135-143.
34. Wachter, H., D. Fuchs, A. Hausen, G. Reibnegger, and E. H. Werner. 1989. Neopterin as a marker for activation of cellular immunity: immunologic basis and clinical application. Adv. Clin. Chem. 27:81-141.